H.R.3082 - Evidence-Based Drug Policy Act of 2025 (119th Congress)
Summary
H.R.3082, the Evidence-Based Drug Policy Act of 2025, seeks to repeal section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998. This section likely pertains to specific regulations or requirements related to drug control policy. The bill is sponsored by Ms. Titus and Ms. Omar and has been referred to multiple committees in the House of Representatives for consideration.
The primary aim of the bill is to remove an existing provision within drug control policy legislation.
This suggests a shift towards a different approach in addressing drug-related issues, potentially emphasizing evidence-based strategies.
Expected Effects
The repeal of section 704(b)(12) would remove the specific requirements or regulations outlined in that section. This could lead to changes in how drug control policies are implemented and enforced.
The impact will largely depend on the content of the repealed section and the subsequent adjustments made to drug control strategies.
It is expected that this change will influence the allocation of resources and the focus of drug control efforts.
Potential Benefits
- Potentially allows for more flexible and adaptive drug policies based on current evidence.
- Could lead to the adoption of more effective strategies for addressing drug-related issues.
- May reduce unnecessary bureaucratic burdens associated with the repealed section.
- Could encourage innovation in drug control approaches.
- May allow resources to be reallocated to more pressing needs within drug control efforts.
Potential Disadvantages
- May remove important safeguards or regulations that were previously in place.
- Could lead to unintended consequences if the repealed section had a positive impact that is not immediately apparent.
- May create uncertainty or instability in drug control policies.
- Could be perceived as weakening efforts to combat drug abuse.
- Potential for increased drug-related problems if the new policies are less effective.
Constitutional Alignment
The bill appears to be within the legislative powers granted to Congress under Article I, Section 8, which includes the power to make laws necessary and proper for carrying into execution the powers vested by the Constitution in the government of the United States. The regulation of drug policy falls under the general welfare clause.
There are no apparent conflicts with specific constitutional amendments, such as the Bill of Rights. The bill does not appear to infringe on individual liberties, rights, or privacy.
However, the constitutionality of the original section 704(b)(12) and the impact of its repeal would need to be considered to ensure full constitutional alignment.
Impact Assessment: Things You Care About ⓘ
This action has been evaluated across 19 key areas that matter to you. Scores range from 1 (highly disadvantageous) to 5 (highly beneficial).